Navigation Links
NxStage® Enters Into New Lease for Corporate Headquarters Within Lawrence, MA
Date:6/29/2011

te buildings creating a unique campus style business environment.  The campus features easy access to public transportation and a friendly, collaborative and professional environment. Riverwalk Properties has a diverse group of corporate tenants, a number of which are in the health care industry.

About NxStage

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Media Contacts:  
Kristen Sheppard, Esq.
Vice President, Investor Relations
NxStage Medical, Inc.
ir@nxstage.com  
978-332-5923


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
2. First NxStage® Home Hemodialysis Patients Celebrate Seven-Year Anniversary
3. NxStage® Appoints Nancy J. Ham to Its Board of Directors and Announces Resignation of Board Member Jonathan T. Silverstein
4. NxStage® to Report Fourth Quarter and Full Year 2010 Financial Results
5. NxStage® Reports Fourth Quarter and Full-Year 2010 Financial Results; Revenue Growth Exceeds Company Guidance
6. In Celebration of the 31st Annual Dialysis Conference, NxStage® Announces Over 5,000 Patients Using the System One™ for Home Hemodialysis
7. New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period
8. NxStage® to Report First Quarter Fiscal 2011 Financial Results
9. NxStage® Names Michael Miller, Jr. President, International
10. Chronic Disease Research Group Study Shows Daily Home Hemodialysis Therapy with the NxStage® System One™ is Associated with Lower Risk of Mortality and Higher Survival Estimates Compared to Conventional Thrice-Weekly Dialysis
11. NxStage® Advances Global Growth Strategy with System One™ Regulatory Approval and Distribution Agreement in Australia and New Zealand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Luoxis Diagnostics, Inc. , a ... MKT: AMPE), today announced an upcoming presentation at ... American Academy of Surgical Trauma (AAST) and Clinical ... Philadelphia, Pennsylvania that will be held ... from a recently completed five-year prospective clinical trial ...
(Date:8/19/2014)... , August 19, 2014 ,Weight ... Pipeline Assessment, 2014, report provides comprehensive insights about phase ... A key objective of the report is to establish ... III pipeline drugs across the different countries and regions. ... thoroughly, the report also provides details on the drug ...
(Date:8/18/2014)... Gamida Cell , a world ... today that it has signed an investment and option agreement ... Novartis " ) . According to the agreement, ... return will receive 15% equity and an option to fully ... period of time following achievement of certain milestones connected to ...
Breaking Medicine Technology:Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 2Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting 3Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 2Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 3Weight Loss Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 4Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 2Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 3Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 4
... - Both co-primary endpoints, Wake After Sleep Onset and ... Sleep, were met at both doses - Evotec to ... 10am EST) today , HAMBURG, Germany | OXFORD, England, ... today positive top-line,results from its first phase II clinical ...
... Summary: Follow-up RAS data presented at ASCO , ... gave,a presentation titled "RAS peptide vaccination in resected,pancreatic ... long term survival" at ASCO's (American Society of ... of 23 resected pancreatic cancer patients,immunized in the ...
Cached Medicine Technology:Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4Pharmexa A/S (DK) - Long lasting immune response and survival to,RAS vaccine 2
(Date:8/20/2014)... “Have you recently been involved in an auto ... lawyer serving the greater Seattle area. “Are you still feeling ... keep reading . , In a recently released article, Dax ... accident can use to see if they may qualify for ... insurance claim will allow an individual to receive medical treatment ...
(Date:8/20/2014)... August 20, 2014 Low market concentration, ... availability of substitutes typify the market for packaging design ... 3.1 out of 5, indicating a moderate level of ... and suppliers have an equal amount of leverage during ... , First, few substitutes exist for packaging design ...
(Date:8/20/2014)... First Choice Emergency Room , the ... United States, named Richard Daniels, DO the Medical Director ... , “We are pleased to announce that Dr. Daniels ... facility in Pflugerville,” said Dr. James M. Muzzarelli, Executive ... Dr. Daniels received his undergraduate degree from Brigham Young ...
(Date:8/20/2014)... 2014 Kowa Optimed returns after a ... debut the new SL-17 portable slit lamp. , The ... LED source controlled by an illuminated thumb wheel for ... uses commercially available AAA rechargeable and dry cell batteries, ... requiring batteries designed specifically for the device. The new ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 This ... line of software defined networking, high availability cloud ... portfolio of Resellers, while allowing OPEN-V to sell ... is pleased to work with OPEN-V on this ... Donald Hows, manager distribution channels at storageFOUNDRY. "Nautilus ...
Breaking Medicine News(10 mins):Health News:Five Questions to Determine Who Qualifies for a Personal Injury Claim Recently Released by The Jones Firm in Recent Article 2Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 4Health News:First Choice Emergency Room Announces Dr. Richard Daniels as Medical Director of the Pflugerville – FM 685 Facility 2Health News:Kowa Optimed (Booth MS13043) to Debut New Portable Slit Lamp at 2014 Vision Expo West in Las Vegas, Nevada 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 3
... 40 million Needy Children and Adults to be Affected Nationwide, Study ... ... A survey released today,by Spectrum Science Communications states that a little known,anti-privatization ... administer its Medicaid program. The,measure, offered as an amendment to the House-passed ...
... afflicted humans, primate ancestors , , FRIDAY, Feb. 29 (HealthDay News) ... as protection against a group of viruses that includes HIV ... that their finding suggests the current AIDS epidemic is not ... in Asian macaques is a hybrid of two existing proteins, ...
... Openings to Feature Cincinnati Reds Great, Doug Flynn, and Pitching ... ... RICHEY, Fla., Feb 29 Zounds,Hearing, a unique manufacturing and retail ... professional,service, opened its doors recently in the Westfield Sarasota Square Mall,(Sarasota) ...
... of Health Professionals Finds Acute Shortage of ... MILPITAS, Calif., Feb. 29 With mounting evidence that,many ... the,nation,s growing epidemic of diabetes, the Johnson & Johnson ... the U.S. to,improve how practitioners deliver diabetes care in ...
... lung cancer, according to a study of more than ... increase the risk of developing it. , Our study ... did not show any evidence for a decreased risk ... Slatore, M.D., of the University of Washington, in Seattle. ...
... diseases like chronic bronchitis, but genes also play a ... Sweden, who studied more than 40,000 Swedish twins to ... each play a role ion the development of chronic ... genetic component and smoking is a primary risk factor ...
Cached Medicine News:Health News:Farm Bill Provision Will Disrupt Arkansas Medicaid Program 2Health News:Farm Bill Provision Will Disrupt Arkansas Medicaid Program 3Health News:Monkey Gene That Blocks AIDS Viruses Evolved More Than Once 2Health News:Zounds! - Sarasota and Port Richey 'Hear' New Retail Concept Coming 2Health News:Zounds! - Sarasota and Port Richey 'Hear' New Retail Concept Coming 3Health News:Johnson & Johnson Diabetes Institute, LLC Launches New Center to Provide State-of-the-Art Education, Training to Health Professionals 2Health News:Johnson & Johnson Diabetes Institute, LLC Launches New Center to Provide State-of-the-Art Education, Training to Health Professionals 3Health News:Johnson & Johnson Diabetes Institute, LLC Launches New Center to Provide State-of-the-Art Education, Training to Health Professionals 4Health News:Johnson & Johnson Diabetes Institute, LLC Launches New Center to Provide State-of-the-Art Education, Training to Health Professionals 5Health News:Certain vitamin supplements may increase lung cancer risk, especially in smokers 2Health News:Genetic factors in smoking also increase risk of chronic bronchitis 2
... MJS anatomic knee ... enhance durability, minimize polyethylene ... surfaces, to minimize contact ... and to achieve a ...
Simplified Design-Based on 15 Years of Experience...
... The result of more than a ... is based on a comprehensive study of ... resection, and tibial insert retrieval analysis.,As a ... axial rotation and motion patterns in total ...
... True to its leadership role within ... the clinical experience of the industry's leading ... Platform Knee System, with the clinically proven ... world's leading rotating platform knee. ,The result ...
Medicine Products: